Compile Data Set for Download or QSAR
Report error Found 387 Enz. Inhib. hit(s) with all data for entry = 12892
TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737906(7-(2-((7-ethyl-1,2,3,4- tetrahydroisoquinolin-6-yl...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737907(7-(2-((7-fluoro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737908(7-(2-((7-fluoro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737909(7-(2-((3-cyclopropyl-1-(piperidin- 4-yl)-1H-pyrazo...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737910(7-(2-((7-chloro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737911(7-(2-((7-chloro-1,2,3,4- tetrahydroisoquinolin-6-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737912(7-(2-((7-chloro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737914(7-(2-((7-ethyl-2-methyl-1,2,3,4- tetrahydroisoquin...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737915(7-(2-((7-ethyl-1,2,3,4- tetrahydroisoquinolin-6-yl...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737916(7-(2-((7-ethyl-2-methyl-1,2,3,4- tetrahydroisoquin...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737919(7-(2-((3-cyclopropyl-1-(piperidin- 4-yl)-1H-pyrazo...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737920(7-(2-((3-cyclopropyl-1-(1- methylpiperidin-4-yl)-1...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737921(7-(2-((7-chloro-1,2,3,4- tetrahydroisoquinolin-6-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737922(7-(2-((7-chloro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737923(7-(2-((7-chloro-1,2,3,4- tetrahydroisoquinolin-6-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737924(7-(2-((7-chloro-1,2,3,4- tetrahydroisoquinolin-6-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737925(7-(2-((6-fluoroisoindolin-5- yl)amino)-5- (trifluo...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737926(7-(2-((7-chloro-1,2,3,4- tetrahydroisoquinolin-6-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737927(7-(2-((6-chloro-1,2,3,4- tetrahydroisoquinolin-7-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737928(7-(2-((6-ethylisoindolin-5- yl)amino)-5- (trifluor...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737929(4-methyl-7-(2-((7-(methylthio)- 1,2,3,4-tetrahydro...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737930(7-(2-((7-chloro-2-ethyl-1,2,3,4- tetrahydroisoquin...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737931(7-(2-((7-chloro-1,2,3,4- tetrahydroisoquinolin-6-y...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737932(7-(2-((6-chloroisoindolin-5- yl)amino)-5- (trifluo...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737935(7-(2-((7-chloro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737936(7-(2-((7-chloro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737937(7-(2-((7-chloro-2-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737939(4-methyl-7-(2-((2-methyl-7- (methylthio)-1,2,3,4- ...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737940(7-(2-((1-(2-(dimethylamino)ethyl)- 3-methyl-1H-pyr...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737941(7-(2-((7-cyclopropyl-1,2,3,4- tetrahydroisoquinoli...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737942(7-(2-((2-ethyl-4-(piperazin-1- yl)phenyl)amino)-5-...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737943(7-(2-((7-ethyl-1,2,3,4- tetrahydroisoquinolin-6-yl...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737945(7-(2-((6-cyclopropylisoindolin-5- yl)amino)-5- (tr...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737947(7-(2-((2-ethyl-6-methylisoindolin- 5-yl)amino)-5- ...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737948(7-(2-((6-chloroisoindolin-5- yl)amino)-5- (trifluo...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737949(7-(2-((6-chloro-2-methylisoindolin- 5-yl)amino)-5-...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737952(4-methyl-7-(2-((7-methyl-1,2,3,4- tetrahydroisoqui...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737953(7-(2-((2-ethyl-7-methyl-1,2,3,4- tetrahydroisoquin...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737954(7-(2-((7-cyclopropyl-2-ethyl- 1,2,3,4-tetrahydrois...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737955(7-(2-((1-(2-(dimethylamino)ethyl)- 3-methyl-1H-pyr...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737956(7-(2-((2-ethyl-7-(methylthio)- 1,2,3,4-tetrahydroi...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737958(7-(2-((2-ethyl-6-fluoroisoindolin-5- yl)amino)-5- ...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737960(7-(2-((2-ethyl-6-methylisoindolin- 5-yl)amino)-5- ...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737961(7-(2-((2-chloro-4-(piperazin-1- yl)phenyl)amino)-5...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737962(7-(2-((2-chloro-4-(4- methylpiperazin-1- yl)phenyl...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737963(7-(2-((2-chloro-4-(4-ethylpiperazin- 1-yl)phenyl)a...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737964(7-(2-((2-ethyl-4-(4- methylpiperazin-1- yl)phenyl)...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737965(7-(2-((2-ethyl-4-(4-ethylpiperazin- 1-yl)phenyl)am...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737966(7-(2-((7-cyclopropyl-1,2,3,4- tetrahydroisoquinoli...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ULK1 [1-649](Homo sapiens (Human))
Erasca

US Patent
LigandPNGBDBM737967(7-(2-((7-cyclopropyl-2-ethyl- 1,2,3,4-tetrahydrois...)
Ligand Info
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 387 total ) | Next | Last >>
Jump to: